#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Congenital generalised lipodystrophy Warm autoimmune haemolytic anaemia Turner's syndrome Cholangitis sclerosing Acute respiratory distress syndrome Pulmonary tuberculosis Thalassaemia alpha Hereditary motor and sensory neuropathy Pancreatic carcinoma metastatic Acquired ATTR amyloidosis Myeloproliferative neoplasm Marginal zone lymphoma refractory Paget's disease of the vulva Cystic fibrosis Endometrial cancer More trials…

    Learn about Rare Diseases

    Sjogren’s syndrome – Life with Disease Leukoencephalopathy – Life with Disease Retinoblastoma – Diagnostics Langerhans cell sarcoma – Basic Information Paroxysmal nocturnal haemoglobinuria – Basic Information Acquired haemophilia – Basic Information Fabry’s disease Medulloblastoma Hereditary optic atrophy – Treatment Angiosarcoma recurrent – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    SKB410 Memantine Hydrochloride Medroxyprogesterone Acetate IMB 101 VX-407 Cefuroxime Sodium Octreotide Isis 678354 Sodium Salt Rly-4008 Lorundrostat Ziclumeran ALE.P03 Degarelix Acetate ENSIFENTRINE Ertapenem Cldn6 Car-T(A) Calcium Chloride Hexahydrate Allopurinol Sodium Mepolizumab Valoctocogene Roxaparvovec More therapies…

    Learn about Your Condition

    Heart transplant Mucopolysaccharidosis I Tourette's disorder Eosinophilic gastritis Prolymphocytic leukaemia Arterial stiffness Supranuclear palsy Albright's disease Mixed-type liposarcoma Neurotrophic keratopathy Lipid metabolism disorder Thymic carcinoma Pelizaeus-Merzbacher disease Acoustic neuroma Diffuse large B-cell lymphoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nutritional and Metabolic Diseases

  • Study on Dasatinib and Quercetin or Nicotinamide Riboside for Patients with Osteoporosis or Osteopenia

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Osteopenia
    • Osteoporosis
    Investigated Drugs:
    • Dasatinib
    Denmark

  • Study on the Safety and Effects of Resatorvid and Filgrastim for Patients with Severe Alcoholic Hepatitis and Acute-on-Chronic Liver Failure

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Acute on chronic liver failure
    • Hepatitis alcoholic
    Investigated Drugs:
    • Resatorvid
    • Filgrastim
    • Placebo
    Germany Portugal Spain

  • Study on the Safety and Effectiveness of Oral Semaglutide for Patients with High Blood Sugar After Kidney Transplantation

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Hyperglycaemia
    • Renal transplant
    Investigated Drugs:
    • Placebo
    • Semaglutide
    Denmark

  • Study on Empagliflozin for Patients with Non-Alcoholic Steatohepatitis (NASH)

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Metabolic dysfunction-associated steatohepatitis
    Investigated Drugs:
    • Empagliflozin
    Czechia

  • Study on Botulinum Toxin Type A for Treating Buerger’s Disease in Patients Eligible for Injection Therapy

    Not yet recruiting

    4 1 1 1
    Investigated Diseases:
    • Thromboangiitis obliterans
    Investigated Drugs:
    • Botulinum Toxin Type A – Haemagglutinin Complex
    France

  • A Phase III Study of Elecoglipron Compared with Semaglutide for Adults with Type 2 Diabetes Mellitus

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Azd5004
    • Semaglutide
    Bulgaria Germany Hungary Italy Poland
Previous Page
1 … 30 31 32 33 34 … 61
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!